Lipoid pneumonia historical perspective: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 2: | Line 2: | ||
{{Lipoid pneumonia}} | {{Lipoid pneumonia}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} {{RG}} | ||
==Overview== | ==Overview== | ||
Revision as of 03:42, 27 September 2019
|
Lipoid pneumonia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Lipoid pneumonia historical perspective On the Web |
|
American Roentgen Ray Society Images of Lipoid pneumonia historical perspective |
|
Risk calculators and risk factors for Lipoid pneumonia historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ramyar Ghandriz MD[2]
Overview
In 1925,G. F. LAUGHLEN, M.D. was the first physician to describe lipoid pneumonia. he first interacted to the disease by routine autopsy at the Toronto, Ontorio hospital for sick children. he described grayish red nodules at the autopsy with three types of exudates, found out mononuclear cells which were unexpected in the exudates.
Historical Perspective
Discovery
- In 1925,G. F. LAUGHLEN, M.D. was the first physician to describe lipoid pneumonia.[1]
- He first interacted to the disease by routine autopsy at the Toronto, Ontorio hospital for sick children.
- He described grayish red nodules at the autopsy with three types of exudates, found out mononuclear cells which were unexpected in the exudates.